Cited by 176Gestational Diabetes Research and ManagementPregnancy and Medication ImpactDiabetes Management and Research

Relationship between haemoglobin A1c in early type 1 (insulin-dependent) diabetic pregnancy and the occurrence of spontaneous abortion and fetal malformation in Sweden

Open access
Hanson, U., Persson, B., Thunell, S.·1990·Diabetologia

Abstract

This prospective nationwide study examined the relationship between diabetic control in early pregnancy as assessed by HbA1C and the incidence of spontaneous abortion and fetal malformation. HbA1C and plasma C-peptide were determined in 532 women with Type 1 (insulin-dependent) diabetes mellitus, corresponding to approximately 80% of all the diabetic pregnancies in the country during the study period 1982-1985, and 222 non-diabetic control women. Median gestational week for sampling was 9.0 in the Type 1 diabetic and 10.0 in the control group. The median value of HbA1C was 7.7% in the diabetic and 5.3% in the control group (p less than 0.001). The rates of spontaneous abortion, 7.7% vs 7.2%, and malformation, 4.3% (major 2.0%) and 2.4% (major 1.0%), were not significantly different between the diabetic and control group, respectively. These rates of malformation were not significantly different from the national figures of 4.55% (major 1.75%). Much elevated HbA1C, i.e., greater than 10.1% equal to 8 SD above the normal mean control value, was significantly associated with the occurrence of spontaneous abortion (p less than 0.001) and malformation (p less than 0.01). Discriminant analysis revealed that after correction had been made for the significant value of HbA1C to predict the occurrence of spontaneous abortion and malformation, no further predictive power was displayed by measurable plasma C-peptide, maternal age or duration of diabetes or presence of diabetic microangiopathy. We conclude that poor metabolic control in early pregnancy contributes to an increased risk of both spontaneous abortion and fetal malformation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/bf00401047

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Women with diabetes who have high haemoglobin A1c levels in the first trimester are at risk of miscarriage and fetal malformation.

    “Women with diabetes who have high haemoglobin A1c levels in the first trimester are at risk of miscarriage and fetal malformation.80”

    From Recurrent MiscarriageGreen‐top Guideline No. 17 (2023) · cites this paper as [80]

    The Abstract and the section ‘HbA1c in relation to occurrence of spontaneous abortion or malformation’ associate very elevated early-pregnancy HbA1c (at least 10.1%) with both outcomes. The study examined women with Type 1 diabetes, so it does not establish the claim for women with diabetes generally or for any level described simply as ‘high.’ (LLM, conf=0.85)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Hanson, U., Persson, B., & Thunell, S.
Affiliations
  • Karolinska University Hospital (SE)
  • Karolinska Institutet (SE)
  • Saint Göran Hospital (SE)
Venue
Diabetologia
Published
1990-02
Volume
33
Issue
2
Pages
100-104
ISSN
  • 0012-186X (ISSN-L)
  • 1432-0428
OpenAlex
W2065618818
Cited by
176
References
17
Citations by year
2025: 3 · 2024: 6 · 2023: 3 · 2022: 2 · 2021: 2 · 2020: 5 · 2019: 2 · 2017: 4 · 2016: 3 · 2015: 4 · 2014: 6 · 2013: 7 · 2012: 6
FWCI
8.17
Type
journal article
Language
en
Open access
Locations
  • Diabetologia (publishedVersion)
  • PubMed (publishedVersion)
Funders
Medical Research Council
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
type 1 diabetes, diabetes in pregnancy, HbA1c, glycemic control, miscarriage, fetal malformations, C-peptide, early pregnancy, pregnancy outcomes
MeSH terms
Congenital Abnormalities, Abortion, Spontaneous, Adult, C-Peptide, Female, Glycated Hemoglobin, Humans, Pregnancy, Pregnancy in Diabetics, Pregnancy Trimester, First, Prognosis, Reference Values, Sweden, Biomarkers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review